Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019.
Bloch EM, Focosi D, Shoham S, Senefeld J, Tobian AAR, Baden LR, Tiberghien P, Sullivan DJ, Cohn C, Dioverti V, Henderson JP, So-Osman C, Juskewitch JE, Razonable RR, Franchini M, Goel R, Grossman BJ, Casadevall A, Joyner MJ, Avery RK, Pirofski LA, Gebo KA. Bloch EM, et al. Among authors: tiberghien p. Clin Infect Dis. 2023 Jun 8;76(11):2018-2024. doi: 10.1093/cid/ciad066. Clin Infect Dis. 2023. PMID: 36740590 Free PMC article.
Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS-CoV-2.
Richier Q, De Valence B, Chopin D, Gras E, Levi LI, Abi Aad Y, Pacanowski J, Meynard JL, Plaçais L, Fey D, Couture P, Martin-Blondel G, Pestre V, Woessner J, Ancellin S, Weyrich P, Carpentier B, Idri S, Tiberghien P, Surgers L, Hueso T, Lacombe K. Richier Q, et al. Among authors: tiberghien p. Influenza Other Respir Viruses. 2024 Mar;18(3):e13272. doi: 10.1111/irv.13272. Influenza Other Respir Viruses. 2024. PMID: 38501337 Free PMC article.
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology.
Cognasse F, Hamzeh-Cognasse H, Duchez AC, Shurko N, Eyraud MA, Arthaud CA, Prier A, Heestermans M, Hequet O, Bonneaudeau B, Rochette-Eribon S, Teyssier F, Barlet-Excoffier V, Chavarin P, Legrand D, Richard P, Morel P, Mooney N, Tiberghien P. Cognasse F, et al. Among authors: tiberghien p. Front Immunol. 2022 Oct 7;13:1034379. doi: 10.3389/fimmu.2022.1034379. eCollection 2022. Front Immunol. 2022. PMID: 36275757 Free PMC article.
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study.
Cognasse F, Hamzeh-Cognasse H, Rosa M, Corseaux D, Bonneaudeau B, Pierre C, Huet J, Arthaud CA, Eyraud MA, Prier A, Duchez AC, Ebermeyer T, Heestermans M, Audoux-Caire E, Philippot Q, Le Voyer T, Hequet O, Fillet AM, Chavarin P, Legrand D, Richard P, Pirenne F, Gallian P, Casanova JL, Susen S, Morel P, Lacombe K, Bastard P, Tiberghien P. Cognasse F, et al. Among authors: tiberghien p. EBioMedicine. 2023 Jan;87:104414. doi: 10.1016/j.ebiom.2022.104414. Epub 2022 Dec 17. EBioMedicine. 2023. PMID: 36535107 Free PMC article.
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial.
Desmarets M, Hoffmann S, Vauchy C, Rijnders BJA, Toussirot E, Durrbach A, Körper S, Schrezenmeier E, van der Schoot CE, Harvala H, Brunotte G, Appl T, Seifried E, Tiberghien P, Bradshaw D, Roberts DJ, Estcourt LJ, Schrezenmeier H. Desmarets M, et al. Among authors: tiberghien p. BMJ Open. 2023 Apr 27;13(4):e071277. doi: 10.1136/bmjopen-2022-071277. BMJ Open. 2023. PMID: 37105693 Free PMC article.
Plasma collection and supply in Europe: Proceedings of an International Plasma and Fractionation Association and European Blood Alliance symposium.
Domanović D, von Bonsdorff L, Tiberghien P, Strengers P, Hotchko M, O'Leary P, Thibert JB, Magnussen K, Erikstrup C, Spekman M, Chesneau S, Jones J, Møller BK, Verheggen P, Gogarty G, Elzaabi M, de Angelis V, Candura F, Mali P, Rossi F, Rodrigues B, Sepetiene R, Lenzen T, Walsemann S, Perry R, Plançon JP, So-Osman C, Durand-Zaleski I, Facco G, Thijssen-Timmer D. Domanović D, et al. Among authors: tiberghien p. Vox Sang. 2023 Sep;118(9):798-806. doi: 10.1111/vox.13491. Epub 2023 Jul 18. Vox Sang. 2023. PMID: 37463772
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
Lacombe K, Hueso T, Porcher R, Mekinian A, Chiarabini T, Georgin-Lavialle S, Ader F, Saison J, Martin-Blondel G, De Castro N, Bonnet F, Cazanave C, Francois A, Morel P, Hermine O, Pourcher V, Michel M, Lescure X, Soussi N, Brun P, Pommeret F, Sellier P, Rousset S, Piroth L, Michot JM, Baron G, de Lamballerie X, Mariette X, Tharaux PL, Resche-Rigon M, Ravaud P, Simon T, Tiberghien P. Lacombe K, et al. Among authors: tiberghien p. BMJ Med. 2023 Oct 27;2(1):e000427. doi: 10.1136/bmjmed-2022-000427. eCollection 2023. BMJ Med. 2023. PMID: 37920150 Free PMC article.
347 results